@mdenton127 @ydeigin these data reveal strong selection on sars-cov-2 during convalescent plasma therapy, which is associated with the emergence of variants that show evidence of reduced susceptibility to neutralizing antibodies in immunosuppressed people.





































































one of the base articles for this post.